CIK 0000886163
- Large accelerated filer
LIGAND PHARMACEUTICALS INC
Sign in to watch- Tickers
- LGND LGNDZ LGNXZ LGNYZ LGNZZ
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 770160744
- Phone
- +1 858-550-7500
- Business address
- 7111 FAIRWAY DRIVE, SUITE 302, PALM BEACH GARDENS, FL, 33418
- Former names
- LIGAND PHARMACEUTICALS
Securities
- LGND Common Stock Nasdaq
- LGNDZ Common stock OTC
- LGNXZ Common stock OTC
- LGNYZ Common stock OTC
- LGNZZ Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,384,247
- in 9 filings, $4.7M under 10b5-1 plans
Net −$7,384,247. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2014-02-27 | Sabba Stephen L Director | Sale | −500 | $72.25 | $36K | 20,546 |
| 2014-02-20 | KNOTT DAVID M Director | Sale | −900 | $72.97 | $66K | 1,843 |
| 2014-02-20 | BVF PARTNERS L P/IL 10% owner | Sale | −18,615 | $73.05 | $1.4M | 279,842 |
| 2014-02-20 | BVF PARTNERS L P/IL 10% owner | Sale | −10,557 | $73.05 | $771K | 158,684 |
| 2014-02-20 | BVF PARTNERS L P/IL 10% owner | Sale | −112,369 | $73.05 | $8.2M | 1,685,344 |
| 2014-02-20 | BVF PARTNERS L P/IL 10% owner | Sale | −5,359 | $73.05 | $391K | 79,390 |
| 2014-02-19 | BVF PARTNERS L P/IL 10% owner | Sale | −9,464 | $73.03 | $691K | 298,457 |
| 2014-02-19 | BVF PARTNERS L P/IL 10% owner | Sale | −5,395 | $73.03 | $394K | 169,241 |
| 2014-02-19 | BVF PARTNERS L P/IL 10% owner | Sale | −57,370 | $73.03 | $4.2M | 1,797,713 |
| 2014-02-19 | BVF PARTNERS L P/IL 10% owner | Sale | −2,771 | $73.03 | $202K | 84,749 |
| 2014-02-18 | BVF PARTNERS L P/IL 10% owner | Sale | −16,915 | $74.66 | $1.3M | 307,921 |
| 2014-02-18 | BVF PARTNERS L P/IL 10% owner | Sale | −16,331 | $74.66 | $1.2M | 174,636 |
| 2014-02-18 | BVF PARTNERS L P/IL 10% owner | Sale | −153,751 | $74.66 | $11.5M | 1,855,083 |
| 2014-02-18 | BVF PARTNERS L P/IL 10% owner | Sale | −14,003 | $74.66 | $1.0M | 87,520 |
| 2014-02-18 | KNOTT DAVID M Director | Sale | −11,531 | $73.31 | $845K | 233,361 |
| 2014-02-18 | KNOTT DAVID M Director | Sale | −3,900 | $73.31 | $286K | 40,796 |
| 2014-02-14 | KNOTT DAVID M Director | Sale | −19,769 | $77.10 | $1.5M | 244,892 |
| 2014-02-14 | KNOTT DAVID M Director | Sale | −6,700 | $77.10 | $517K | 44,696 |
| 2014-02-14 | Aryeh Jason Director | Sale | −9,500 | $78.87 | $749K | 244,716 |
| 2014-02-14 | FOEHR MATTHEW W EVP and COO | Exercise or conversion | +3,444 | $9.97 | $34K | 53,457 |
Page 75 of 86 · 1,712 trades